Stay updated with breaking news from Human Use. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SOUTH PLAINFIELD - PTC Therapeutics, Inc. announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency issued a negative opinion following the...
By Colin Kellaher Bristol Myers Squibb on Friday said the European Medicines Agency's Committee for Medicinal Products for Human Use recommended approval of earlier use of the Abecma gene...
WALTHAM, Mass., Jan. 26, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency
OPENING CALL Stock futures fell as a disappointing sales outlook from Intel had traders pushing equities lower. Intel shares were down more than 10% in premarket trading, and the selloff... -January 26, 2024 at 06:22 am EST - MarketScreener
Apellis Pharmaceuticals, Inc. (APLS) announced that the European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP has adopted a negative opinion for Pegcetacoplan for geographic atrophy or GA.